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Abstract
Humans inhale hundreds of Aspergillus conidia without adverse consequences. Powerful protective mechanisms may ensure
prompt control of the pathogen and inflammation. Here we reveal a previously unknown mechanism by which the danger
molecule S100B integrates pathogen– and danger–sensing pathways to restrain inflammation. Upon forming complexes
with TLR2 ligands, S100B inhibited TLR2 via RAGE, through a paracrine epithelial cells/neutrophil circuit that restrained
pathogen-induced inflammation. However, upon binding to nucleic acids, S100B activated intracellular TLRs eventually
resolve danger-induced inflammation via transcriptional inhibition of S100B. Thus, the spatiotemporal regulation of TLRs
and RAGE by S100B provides evidence for an evolving braking circuit in infection whereby an endogenous danger protects
against pathogen–induced inflammation and a pathogen–sensing mechanism resolves danger–induced inflammation.
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Introduction
Inflammation results from recognition of invading microorgan-
isms through pathogen–associated molecular patterns (PAMPs)
and from reaction to tissue damage–associated molecular patterns
(DAMPs) [1,2]. It is known that the innate immune system
recognizes both PAMPs and DAMPs through pattern recognition
receptors, such as Toll–like receptors (TLRs) and other receptors
[3,4,5,6]. Multiple positive feedback loops between DAMPs and
PAMPs and their overlapping receptors temporally and spatially
drive immune regulatory functions. Despite the identification of
specific signaling pathways negatively regulating responses to
PAMPs or DAMPs [7,8], the unexpected convergence of
molecular pathways responsible for recognition of PAMPs and
DAMPs raised the question of whether and how the host
discriminates between these two molecular patterns [9,10].
DAMPs such as the high mobility group box 1 protein
(HMGB1) and S100 proteins represent important danger signals
that, although primarily intracellular, may mediate inflammatory
responses through autocrine/paracrine interactions with the
receptor for advanced glycation end–products (RAGE), a multi-
ligand receptor of the immunoglobulin superfamily [3,4,5,11,12].
Integral to the biology of RAGE and its ligands is their up–
regulation and increased accumulation in multiple biological and
disease settings. The ability to activate expression programs that
encode innate immune responsive genes confers to RAGE a
central role in chronic inflammatory diseases.
Engagement of RAGE converts a brief pulse of cellular
activation to sustained cellular dysfunction, eventually leading to
inflammation [4] and tumor promotion [13]. However, because
RAGE is expressed in multiple, distinct cell types, including
immune cells, and both murine and human RAGE genes undergo
extensive splicing with distinct splice isoforms being uniquely
distributed in different tissues [14], it is not surprising that diverse
signal transduction and effector pathways may be impacted by
RAGE depending on sites, ligands and time course of ligand–
RAGE stimulation [15,16,17]. The complexity of the system is
enhanced by the findings that the ligands of RAGE may interact
with distinct TLR–binding molecules thus amplifying inflamma-
tory and immune responses in infection [11,18,19,20]. Thus,
although promoting pathology, RAGE signaling also contributes
to beneficial, inflammatory mechanisms of repair, in certain
settings [5]. Ultimately, discerning the primal versus the chronic
injury–provoking roles for this ligand–receptor interaction is a
challenge in delineating the functions of the ligand/RAGE axis
[21].
Given that RAGE is expressed at the highest levels in the lung
compared to other tissues [5,22] and both protects and causes lung
injury [5], the DAMP/RAGE axis likely integrates with the
PAMP/TLR axis in the inflammatory responses in lung infections.
We have addressed whether and how the two systems interact in a
mouse model of pulmonary infection with a model fungal
pathogen as well a common cause of severe infections and
diseases, Aspergillus fumigatus [23]. Humans inhale hundreds of
conidia per day without adverse consequences [24], except for a
small minority of persons in whom defense systems fail and a life–
threatening angioinvasive form of aspergillosis can develop. Some
degree of inflammation is required for protection during the
PLoS Pathogens | www.plospathogens.org 1 March 2011 | Volume 7 | Issue 3 | e1001315transitional response occurring between the rapid innate and
slower adaptive response. However, progressive inflammation
worsens disease and ultimately prevents pathogen eradication, a
condition in which it is an exaggerated inflammatory response that
likely compromises a host’s ability to eradicate infection and not an
‘‘intrinsic’’ susceptibility to infection that determines a state of
chronic or intractable disease [25]. We disclosed the complexity of
signalling integration between different innate immune biosensors
by showing that the spatiotemporal regulation of TLRs and
RAGE by S100B limits pathogen– as well as danger–induced
inflammation and ensures protection in infection.
Results
RAGE and DAMPs expression in pulmonary aspergillosis
We assessed the expression of RAGE in the lungs of mice
infected with Aspergillus conidia by immunohistochemical staining,
protein and gene expression analysis. RAGE expression was
observed at mRNA (Fig. 1A and Fig. S1A)a n dp r o t e i n( Fig. 1B)
levels and maximally occurred in alveolar epithelial cells, as
revealed by immunofluorescence staining (Fig. 1D). On assessing
which putative ligands of RAGE were concomitantly expressed in
infection, we found that HMGB1 was not increased either at the
level of gene (Fig. 1A and Fig. S1A)o rp r o t e i n( Fig. 1B)
expression. In contrast, S100B was promptly induced in infection,
and declined thereafter to return to basal levels a week later, as
revealed by gene and protein expression analysis in the lung
(Fig. 1A,B and Fig. S1A) and protein secretion in the
bronchoalveolar lavage fluid (BAL) (Fig. 1C). S100B immuno-
reactivity was high in bronchiolar epithelial cells as revealed in
wild–type mice (WT) (immunofluorescence staining in Fig. 1D)
or in transgenic mice expressing s100b–EGFP+ (Fig. 1E).
Further analysis on purified lung cells from transgenic mice
confirmed that epithelial cells were major sources of S100B in
infection (Fig. S1B)w h i l eAger was expressed on epithelial cells,
macrophages, dendritic cells (DCs) (Text S1) and polymorpho-
nuclear neutrophils (PMNs) (Fig. S1C), as described [5].
Presumably associated with PMNs’ infiltration, s100a8 and
s100a9 expressions in the lung mainly occurred at 3 days post–
infection (Fig. 1A). These data suggest that S100B pairs with
RAGE very early in infection before its transcriptional downreg-
ulation. The prompt induction of S100B followed by its
downregulation suggests that S100B may serve as a danger
signal to control inflammation.
RAGE–deficient mice develop pathogen–induced
inflammation
To determine the role of the S100B/RAGE axis in response to
the fungus, we evaluated parameters of infection, inflammation
and adaptive immunity in RAGE KO mice with pulmonary
aspergillosis. Despite an initial higher fungal growth in the lung
and brain of KO than WT mice, the fungal growth was eventually
restrained in both types of mice (Fig. 2A). Inflammation and signs
of parenchyma damage, in contrast, were greatly exacerbated in
RAGE KO mice and failed to resolve as opposed to WT mice
(Fig. 2B, upper panels with fungi magnified in the inset). The
number of PMNs increased and maintained elevated in the lung
parenchyma and the BAL fluids (Fig. 2B, lower panels and inset)
of RAGE KO mice. Gene expression analysis of the lung
confirmed the higher and persistent inflammatory response in
KO than WT mice, as revealed by the higher mRNA expression
of Cxcl1, Cxcl2 and Mpo genes as well as genes for inflammatory
cytokines, such as IL–1b and IL–6 (Fig. 2C).
Despite the fact that an inflammatory response was not
observed upon challenge with inactivated conidia (data not
shown), the failure to resolve inflammation was not secondary to
either a deficient conidiocidal activity of lung cells, including
macrophages (Fig. 2D), or a defective oxidant production
(Fig. 2E). PMNs only from KO mice showed between 25 to
35% reduction of their conidiocidal activity as compared to WT
mice, a finding pointing to a requirement for RAGE in the
execution of PMNs’ effector activity. These data indicate that
RAGE, known to mediate PMN recruitment through interaction
with beta 2 integrins [26], is neither required for lung
inflammatory cell recruitment or oxidant production in aspergil-
losis but unexpectedly protects from unintended inflammation.
Both the subverted innate inflammatory response to the fungus
[25] and the requirement for RAGE in DC and T cell functions
[27,28] would predict altered adaptive Th responses to the fungus.
This was indeed the case as shown by the results of lung DC and
Th cell activation in response to the fungus. Purified DCs from
RAGE KO mice responded to Aspergillus conidia or hyphae with
higher expression level of mRNA for IL–1b, IL–6, IL–23 (p19),
and similar levels of IL–12 (p35) or IL–10 compared to WT DCs
(Fig. S2A). Of interest, similar to the response to the fungus,
higher levels of inflammatory cytokines were also observed in KO
vs WT DCs in response to the TLR2/TLR6 ligand bacterial
lipopeptide macrophage–activating lipopeptide (MALP–2) but not
to LPS or ODN–CpG (Fig. S2B). In terms of Th cell activation,
although cytokine and transcription factor mRNAs were higher in
unstimulated CD4+T cells from KO than WT mice, a further
increased was observed for Th2 (Gata3/Il4) or Th17 b(Rorc/Il17a)
but not for Th1 (Tbet/Ifnc) or Treg (Foxp3/Il10) specific transcripts
(Fig. S2C). Thus, RAGE deficiency is associated with deregulated
innate and adaptive antifungal immunity and the inflammatory
program activated in DCs in response to the fungus/TLR ligands
is compatible with the impairment of antifungal Th1/Treg
protective responses and upregulation of inflammatory Th2/
Th17 cell responses [29,30].
RAGE pairs with S100B for anti–inflammatory and pro–
inflammatory signals
To formally prove that RAGE pairs with S100B in infection,
experiments of S100B neutralization or administration were
performed. We found that S100B neutralization decreased
resistance to infection in WT mice as indicated by the increased
fungal growth (Fig. 3A), PMN recruitment and inflammation in
the lung (Fig. 3B), an effect that was mimicked by treatment with
Author Summary
Inflammation results from recognition of invading micro-
organisms through pathogen–associated molecular pat-
terns (PAMPs) and from reaction to tissue damage–
associated molecular patterns (DAMPs). Despite the
identification of specific signaling pathways negatively
regulating responses to PAMPs or DAMPs, the unexpected
convergence of molecular pathways responsible for
recognition of either one raised the question of whether
and how the host discriminates between the two distinct
molecular patterns. Here we reveal a previously unknown
mechanism by which the danger molecule S100B inte-
grates pathogen– and danger–sensing pathways to
restrain inflammation in Aspergillus fumigatus infection.
By disclosing protective mechanisms that ensure prompt
control of the pathogen and inflammation, our results may
help to explain why humans inhale hundreds of Aspergillus
conidia without adverse consequences.
TLR/RAGE Cross-Talk in Inflammation
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ingly, exogenously administered S100B decreased the fungal
growth and the inflammatory pathology, but this occurred at
nanomolar doses ranging from 5 to 50 ng/kg but not at doses up
to 5000 ng/kg (Fig. 3A,B). Both effects were RAGE–dependent
being abrogated, albeit partially for low–dose S100B, in RAGE
KO mice (Fig. 3A). Similar experiments done for HMGB1 (Text
S1) showed that the fungal burden and inflammation were both
increased upon its administration and involved RAGE (Fig. S3).
Because S100B itself didn’t show a direct activity on fungal growth
Figure 1. RAGE and DAMPs expression in pulmonary aspergillosis. Expression of RAGE, HMGB1, S100B, S100A8 and S100A9 by RT–PCR (A),
western blotting (B, C) and immunoistochemical staining (D) on the lungs of C57BL6 mice infected with Aspergillus conidia intranasally at different
days postinfection (dpi). In C, S100B was assessed on BAL by western blotting. For immunohistochemistry, lung sections were incubated overnight
with anti–S100B or anti–RAGE antibody followed by the secondary antibodies. Nuclei were counter–stained with DAPI. (E) Lung sections from
transgenic mice expressing s100b–EGFP+ at different days postinfection. Bars, 100 mm. Microscopy was performed on a DM Rb epifluorescence
microscope equipped with a digital camera. Representative of 2 experiments.
doi:10.1371/journal.ppat.1001315.g001
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given before the infection (data not shown), these data suggest that
S100B pairs with RAGE for anti– and pro–inflammatory
activities, a feature consistent with the unique ability of S100B
to exhibit opposite effects depending on doses [12,17,31].
Mechanistically, we assessed whether S100B affected the
activation of nuclear factor kB (NF–kB) and oxidant production,
important inflammatory pathways downstream RAGE activation
[3,4] in vivo and in vitro on purified PMNs, known to respond to
S100B [12]. In vivo, 500, but not 50, ng/kg S100B promoted
Figure 2. RAGE–deficient mice develop pathogen–induced inflammation. Fungal growth (CFU6SE) (A), lung histology (PAS, H&E and
Gomori stainings) and BAL morphometry (B), inflammatory chemokines and cytokine gene expression in the lungs by real–time RT–PCR (C),
conidiocidal activity (D), oxidant production (E) in mice infected with live Aspergillus conidia intranasally. Note the sustained parenchymal damage
(PAS staining in the upper panel of Fig. 2B), fungal growth (Gomori staining in the inset), and inflammatory cell recruitment in lungs (H&E staining in
the lower panel) and BAL (May–Gru ¨nwald Giemsa–staining in the inset) in RAGE KO mice. Bars indicated magnifications. Dpi, days postinfection. BAL
morphometry (numbers refer to % polymorphonuclear (PMN) or mononuclear (MNC) cells), lung RT–PCR, conidiocidal activity and oxidant
production were assessed 3 days after the infection. Total lung cells, purified alveolar macrophages and PMNs were incubated with unopsonized
resting conidia at 37uC for conidiocidal activity [percentage of colony forming units’ inhibition (mean 6 SE) at 60 min] or oxidant production by DHR.
PMA, phorbol 12–myristate 13–acetate. *P, KO vs WT mice. Data are pooled from 4 experiments or representative of 2 experiments (for histology).
doi:10.1371/journal.ppat.1001315.g002
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PLoS Pathogens | www.plospathogens.org 4 March 2011 | Volume 7 | Issue 3 | e1001315Figure 3. Effects of S100B administration or neutralization on aspergillosis. Fungal growth (CFU6SE) (A), lung histology (PAS staining) and
BAL morphometry (May–Gru ¨nwald Giemsa–staining in the inset) (B) in C57BL6 or RAGE KO mice infected with Aspergillus live conidia intranasally and
treated intraperitoneally for 3 consecutive days with different doses (ng/kg) S100B, 1 mg/kg anti–S100B or 0.5 mg/kg anti–RAGE antibodies. P,
treated vs untreated (–) mice. NF–kB activation was assessed by western blotting (C) on lung cells from WT and KO mice, untreated (–) or treated with
50 or 500 ng/kg S100B, a day after the last treatment, or by nuclear translocation (indicated by arrowheads in D) on purified PMNs, unexposed (Ct,
control) or exposed in vitro for 60 min to Aspergillus conidia alone (–) or in the presence of S100B at 4 nM or 4 mM. Western blotting data are
presented as immunoblots of cell lysates with phosphorylation–specific antibodies and fold increases (pixel density) in the phosphorylated to total
protein ratios. (E) Oxidant production was assessed PMNs exposed as in D (by DHR at 60 min). (F) Fas and Bcl2 expressions were assessed by real–
time RT–PCR after 6 h–exposure. Representative of 3 experiments. *P,0.05, treated vs untreated (–) cells.
doi:10.1371/journal.ppat.1001315.g003
TLR/RAGE Cross-Talk in Inflammation
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vitro, micromolar but not nanomolar S100B activated NF–kB
(Fig. 3D) and increased oxidant production in response to the
fungus (Fig. 3E). Interestingly, and consistent with the dose–
dependent prosurvival/prodeath effects of S100B on cells [32], Fas
expression was decreased and antiapoptotic Bcl2 expression
increased in WT and KO PMNs exposed to nanomolar S100B
and the opposite was true with micromolar S100B acting via
RAGE (Fig. 3F). These data confirm that RAGE activation by
S100B is dependent on doses and also suggest that S100B may
possess characteristics beyond the RAGE activating function
which mediate its anti–inflammatory effects.
The S100B/RAGE axis restrains TLR2/MyD88–dependent
inflammation
Danger–sensing mechanisms are known to participate in the
TLR responses to PAMPs [11,20] and to negatively regulate
excessive inflammation during infection [10]. Given the ability of
HMGB1 to bind and act in synergy with endogenous and
exogenous TLR ligands [11,33], we assessed whether S100B also
binds TLR ligands in solid phase by ELISA. We found that S100B
highly binds exogenous and endogenous TLR ligands, such as
MALP–2, HSP70, class B ODN–CpG (ODN 1982), mammalian
DNA, fungal RNA and, partly, DNA, in a Ca
2+–and dose–
dependent manner, with the maximum binding activity observed
at the nanomolar dose (Fig. 4A). No binding was observed to
Zymosan, LPS, double–stranded RNA [polyinosinic–polycytidylic
acid, Poly(I:C)], non-CpG ODN (ODN 1982) or single–stranded
RNA (the imidazoquinoline resiquimod R848). These data suggest
that S100B may interact with TLR2 (HSP70) but not with Dectin–
1 (Zymosan), with the heterodimer TLR2/TLR6 (MALP–2) and
with intracellular nucleic acid–sensing TLRs.
Because TLR2 activates the inflammatory state of PMNs in
infection [34,35] and unrestrained inflammation occurred in
condition of defective S100B/RAGE axis, we hypothesized that
the S100B/RAGE axis may inhibit TLR2/MyD88–driven
inflammation to the fungus. We assessed therefore whether and
how nanomolar or micromolar S100B would affect TLR2–
mediated activation of PMNs. We found that ERK phosphory-
lation in response to MALP–2 was inhibited by nanomolar S100B
and potentiated by micromolar S100B or by blocking serum
S100B. This occurs through a p38–dependent mechanism, as
shown by the ability of nanomolar S100B to induce p38–
phosphorylation as well as ERK phosphorylation in the presence
of the specific p38 inhibitor SB202190. Like micromolar S100B,
HMGB1 activated ERK more than p38 phosphorylation
(Fig. 4B). These data indicate that S100B, like HMGB1 [11],
potentiates the biological activity of TLR2 ligands upon forming
complexes with them.
However, they also unexpectedly revealed that forming
complexes with nanomolar S100B negatively regulates their
functions. That p38 is a negative regulator of TLR2 expression
has already been described [36]. We assessed here whether
inhibition of TLR2 occurred through physical association by
performing immunoprecipitation studies with TLR2–transfected
HEK cells stimulated with MALP–2, in the presence or not of
S100B. Both RAGE and TLR2 were found to associate with
nanomolar or micromolar S100B upon TLR2 stimulation, but
TLR2 physically associated with RAGE only in the presence of
nanomolar S100B (Fig. 4C). Although RAGE was found to be
expressed in TLR2–transfected HEK 293 cells (unpublished
observations), we transiently transfected TLR2–HEK 293 cells
with RAGE to visualize the RAGE/TLR2 interaction using the in
situ proximity ligation assay. We confirmed that RAGE strongly
interacts with TLR2 in the presence of nanomolar but not
micromolar S100B. In addition, the lack of interaction observed
upon S100B neutralization suggests that endogenous S100B likely
mediates TLR2/RAGE physical interaction in steady-state
conditions (Fig. 4D). Thus, S100B interacts with RAGE and
TLR2 and mediates the physical association of the two at
nanomolar doses. Because S100B production mainly occurred in
infection via the TLR2/MyD88 pathway (Fig. 4E, F), our
findings indicate the existence of an autocrine/paracrine loop by
which TLR2–induced S100B binds to extracellular RAGE to
inhibit TLR2 upon physical association. This scenario would
suggest an increased responsiveness to TLR2–mediated inflam-
mation of RAGE KO mice. Consistent with the high reactivity of
DCs to MALP–2 (Fig. S2B), the inflammatory response to
intranasally delivered MALP–2 was higher in RAGE KO than
WT mice as compared to other TLR agonists the sensitivity to
which was not different between KO and WT mice (Fig. 4G).
TLR3/9 signaling inhibits S100B expression via TRIF/
noncanonical NF–kB
The finding that S100B production in vivo was upregulated in
the absence of TLR3 and TRIF, conditions in which we noticed a
defective transcriptional downregulation of S100B (Fig. 4E), led
us to suppose that binding to intracellular nucleic acids is a
mechanism by which S100B is down-regulated and its pro–
inflammatory activity restrained in infection. We resorted to lung
epithelial cells as major sources of S100B in infection. We assessed
p38 phosphorylation in cells from WT and selected TLR–KO
mice exposed to Aspergillus resting (RC) or swollen (SC) conidia,
MALP–2, Poly(I:C) or ODN–CpG and the relative contribution of
endogenous S100B. We found that p38 phosphorylation occurred
maximally in response to Aspergillus RC and Poly(I:C), to a lesser
extent in response to ODN–CpG and SC, did not occur in
response to MALP–2, and was largely TLR3/TLR9/TRIF–
dependent, but MyD88–independent (Fig. 5A). Both Ifnb1 and
Ifna1 gene expression in response to Poly(I:C) were unaffected
upon the addition of S100B but decreased upon neutralizing
S100B by siRNA (Fig. 5B), a finding indicating that S100B
participates in the functional sensing of intracellular nucleic acids
by TLR3. Although similar results were obtained in response to
ODN–CpG, the overall responsiveness of epithelial cells to TLR9
was lower (data not shown), as already reported [37]. In terms of
source of intracellular nucleic acids, consistent with the binding
activity of S100B in vitro, we found that fungal RNA not only
complexes with S100B in infection (Fig. 5C) but also activates
epithelial cells in a TLR3–dependent manner, as indicated by
IRF3 phosphorylation (Fig. 5D).
The transcriptional downregulation of s100b in infection led us
to hypothesize that transcription factors downstream p38/TRIF
would mediate this effect. Given the existence of specific binding
sites for NF–kB family members in the promoter of both human
(GenBank: M59486) and murine (GenBank: NC_000076.5)
S100b, we assessed whether NF–kB transcription factors regulate
s100b gene expression. For this purpose, we evaluated the
activation of canonical/noncanonical NF–kB pathways down-
stream TLR2/MyD88 and TLR3/TLR9/TRIF and their
contribution to s100b gene expression. Of the two IkB kinase
complex catalytic subunits, known to have opposing roles in
inflammation [38], IKKb more than IKKa was phosphorylated in
response to SC, MALP–2, the opposite was true in response to
Poly(I:C), while both pathways were activated by ODN–CpG
(Fig. 5E). We also quantified the activation of the NF–kB family
members, using an ELISA kit specific for mouse p65, p52 and
RelB. Significant nuclear translocation occurred for p52 and RelB,
TLR/RAGE Cross-Talk in Inflammation
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Significant translocation of all members was observed in response
to ODN–CpG, while only p65 translocation occurred in response
to MALP–2 (Fig. 5F). The two pathways had opposite effects on
S100b gene expression, as shown by experiments in which either
pathway was silenced by siRNA. S100b expression was inhibited
upon blocking the canonical pathway or promoted upon blocking
the noncanonical, p38-dependent, pathway (Fig. 5G). These data
suggest that s100b expression is transcriptionally regulated by the
sequential action of downstream MyD88– and TRIF–dependent
NF–kB signalling pathways.
S100B activity in vivo is contingent upon TLRs
Experiments in vivo confirmed that the pro- and anti-
inflammatory activity of S100B is contingent upon these TLRs.
The anti–inflammatory activity of nanomolar S100B, as revealed
by the fungal growth restriction and PMN recruitment, occurred
independently of TLR4 but required the presence of TLR2,
TLR6 and the MyD88 adaptor. Consistent with the ability of the
TLR3/TLR9/TRIF pathway to downregulate s100b, S100B
became pro–inflammatory at the nanomolar dose in the relative
absence of TLR9, TLR3 and the adaptor TRIF (Fig. 6A, B).
These in vivo findings confirm that the spatiotemporal integration
of signals from TLRs and RAGE by S100B limits pathogen– and
danger–induced inflammation in murine aspergillosis (Fig. 7).
Discussion
To initiate an appropriate inflammatory response, organisms
have developed ways to recognize potentially life–threatening
signals. Our study reveals that sequential signaling between
different innate immune biosensors serves to limit pathogen–
and danger– induced collateral inflammation in infection. This
occurs through a previously undescribed TLR/RAGE interaction
via S100B, an EF–hand calcium–binding protein, with both intra–
and extracellular activities, that acts in either an autocrine or
paracrine manner through RAGE [12,15].
RAGE is known to interact with TLR9 via HMGB1 which
results in either a potentiation [19] or suppression [39] of TLR9
function. We found that, upon engagement, RAGE associated
with and inhibited TLR2. This occurred through epithelial cell–
released S100B that paracrinally inhibited the TLR2–dependent
activity of recruited PMNs, a finding consistent with the ability of
RAGE to impair neutrophil functions [40] as well as with the
down–regulated TLR2 activity in pulmonary aspergillosis [41].
PMNs’ recruitment is a characteristic feature of pulmonary
aspergillosis [23] and PMNs’ activity is tightly regulated by TLRs
[34]. RAGE was dispensable for PMNs’ recruitment but potently
regulated TLR2–induced MAPK kinase activation, NF–kB
phosphorylation and survival, via low, but not high, doses of
S100B. Notably, the ability of S100B to bind TLR2 also predicts
an activity on TLR2 in a RAGE-autonomous fashion. Therefore,
consistent with the biology of RAGE and its ligands [3,42], their
up–regulation exerted a proximal role in the inflammatory
cascade. However, at least for extracellular S100B, the interaction
with RAGE also served to limit pathogen–induced inflammation.
Thus, S100B plays a dual role in infection, restraining the
inflammatory response in the early response to pathogen, through
a paracrine epithelial cells/PMNs braking circuit, but also
contributing, similar to HMGB1, to excessive inflammation
through feed–forward RAGE activation [26] and likely through
additional TLR interactions.
The opposite effects on cells observed with low and high doses
of S100B could be mechanistically explained by considering that
calcium binding triggers structural changes in the S100 protein
that allow interaction with target proteins as an octamer or a
higher-order multimer form [16]. Trophic vs toxic effects are
observed on neuronal cells in which nanomolar S100B stimulate
neurite growth and promote survival, while micromolar levels
result in inflammatory effects [32,43]. Structural and biochemical
data have provided evidence that octameric S100B is highly
stable and triggers RAGE activation by receptor dimerisation
resulting in high–affinity binding [15,16] to the RAGE V and
C(1) domains activating NF–kB [15]. Both domains are
important for ligand binding and for intracellular signaling,
respectively. In contrast, nanomolar S100B required RAGE to
inhibit TLR2 for the elaboration of its anti–inflammatory
activity. We have already shown that some S100B–induced
cellular effects may not depend on RAGE signalling yet requiring
the receptor [44]. This appears to be the case in our model in
which the ability of S100B to bind endogenous and exogenous
TLR2 ligands may offer a plausible molecular explanation for
RAGE/TLR2 physical association. How this may prevent TLR2
signalling is not obviously clear, although signalling by TLR2
upon binding of ligands possessing fatty acyl moieties suggests a
dynamic model of interaction, in which only a specific orientation
of the ligand favors formation of a signal inducing ternary
complex [45]. Thus, similar to HMGB1 [11], S100B, by forming
complexes with various TLR ligands, may present the partner
molecule to its normal receptor in a way in which the
conformation of the partner molecule is changed or in an
allosteric interaction with the receptor or both.
Figure 4. The S100B/RAGE axis restrains TLR2/MyD88–dependent inflammation. (A) Binding of S100B to TLR ligands by ELISA. S100B was
incubated in microtiter plates coated with 10 mg/ml (as by preliminary experiments) of MALP–2, Zymosan, HSP70, LPS, Poly(I:C), fungal DNA or RNA,
mammalian genomic DNA, Class B ODN–CpG (2006), nonstimulatory ODN–CpG (2310) and R–848 with and without 1 mM EGTA. Data indicate the
mean 6SE of triplicates from three independent experiments. *P,0.05, S100B vs no S100B (–). (B) Levels of ERK1/2 or p38 MAPK (30 min) in purified
PMNs exposed to 5 mg/ml MALP–2, nanomolar or micromolar S100B, 20 mg/ml anti–S100B antibody, 5 mM SB202190, 300 nM HMGB1, alone or in
combination, for 30 min as described. Data are presented as immunoblots of cell lysates with phosphorylation–specific antibodies and fold increases
(pixel density) in the phosphorylated to total protein ratios. Representative of 2 experiments. (C) TLR2-transfected HEK293 cells were stimulated with
MALP–2 for 30 min with and without 4 nM or mM S100B or 20 mg/ml anti–S100B antibody. Cell lysates were subjected to immunoprecipitation after
overnight incubation with 2 mg/ml polyclonal anti–S100B or anti–RAGE antibody. Immunoprecipitates were probed with antibodies to the
corresponding antigens. RT-PCR analysis confirmed that both RAGE and S100B were expressed on tranfected HEK293 cells and experiments in KO
cells confirmed the specificity of the anti-RAGE antibody (data not shown). Representative of 2 experiments. (D) Direct visualization of RAGE
interaction with TLR2 in the presence of nanomolar S100B by in situ proximity ligation assay (PLA). TLR2-transfected HEK293 cells were transiently
transfected with a RAGE expression vector (pcDNA3/RAGE) or empty vector (pcDNA3) and stimulated with MALP–2 for 30 min with or without 4 nM
or mM S100B or 20 mg/ml anti–S100B antibody. Cells were stained with anti-RAGE and anti-TLR2 antibodies, and subjected to PLA. (E) s100b gene–
expression by real–time RT–PCR in different TLR-deficient mice at different days postinfection (dpi) with Aspergillus conidia intranasally. *P,0.05, dpi
1 and 3 vs 0. (F) S100b gene–expression by real–time RT–PCR in lung of C57BL6 mice injected with 2.5 mg MALP–2, 10 mg LPS, 50 mg Poly(I:C), 50 mg
Class B ODN–CpG 3 days before. P, treated vs untreated (–) mice. (G) H&E–stained sections from C57BL6 or RAGE KO mice injected as in F, 3 days
before. Representative of 2 experiments.
doi:10.1371/journal.ppat.1001315.g004
TLR/RAGE Cross-Talk in Inflammation
PLoS Pathogens | www.plospathogens.org 8 March 2011 | Volume 7 | Issue 3 | e1001315TLR/RAGE Cross-Talk in Inflammation
PLoS Pathogens | www.plospathogens.org 9 March 2011 | Volume 7 | Issue 3 | e1001315The ability of S100B to bind nucleic acids, while qualifying
S100B as possible sentinel for nucleic acid–mediated immune
activation [20], also serves to explain the intracellular function of
S100B in epithelial cells in infection. It is known that, upon
calcium binding, the change of conformation in the C–terminal
domain of S100B allows the exposure of hydrophobic residues
critical for the binding to a variety of target proteins [46], thereby
affecting their activities and allowing the elaboration of a variety of
intracellular functions [12]. We found that S100B was able to
bind, in a calcium–dependent manner, Class B ODN–CpG,
mammalian DNA and fungal RNA and DNA, resulting in the
activation of a p38/TRIF–dependent signalling, downstream
TLR3 and TLR9. Thus, intracellular S100B may signal trough
both TLR3 and TLR9 to scavenge pathogen– and host–derived
nucleic acids. Of interest, at variance with HMGB1 [19], S100B
also discloses a TLR9–depending signalling pathway that
converges on TRIF rather than on MyD88 [7]. The molecular
basis for this result in epithelial cells is presently under
investigation, but is consistent with the finding that modification
of the structure of the DNA ligand affects its sub–cellular
localization and this may impact on sorting and signaling adapters
as well as the biological response to TLR9 activation in DCs
[47,48]. That S100B may affect the intracellular compartmental-
ization of DNA upon binding pathogen and self DNA is,
ultimately, a likely expectation for a chaperon molecule that
localizes to the cytoplasm in a soluble form and in complexes with
cytoskeletal and filament–associated target proteins [31]. This may
also predict an inherent risk of autoimmunity associated with
S100B. Incidentally, elevated levels of S100B have been observed
in certain immuno–mediated diseases [12].
In addition to binding fungus DNA, whose unmethylated CpG
motifs activates TLR9 [49], S100B also bound fungal RNA, a
PAMP able to activate DCs for antifungal priming [50]. That
endogenous mRNA [51] and pathogen RNA [52] activate TLR3
is an established finding. We found that endogenous S100B binds
fungal RNA and activation of epithelial cells by fungal RNA is
TLR3–dependent. Thus, in addition to sensing tissue necrosis
[53], TLR3, abundantly expressed on epithelial cells [37],
functions as an endogenous sensor of fungal RNA. Even more
interesting is the finding that the activation of the TRIF–
dependent, nucleic acid sensing pathway, mainly considered an
inducer of antimicrobial innate immune responses, contributes to
resolution of inflammation in infection. This occurs by downreg-
ulating s100b gene expression transcriptionally via noncanonical
NF–kB signalling. Although s100b gene expression is tightly
regulated in human cells [54], little is known about mechanisms
regulating its transcription. The transcriptional regulation of s100b
expression by the sequential action of downstream MyD88– and
TRIF–dependent NF–kB signalling pathways is thus a novel
finding that not only establishes a link between pathogen– and
danger–sensing signaling pathways but also confirms the inhibitory
role of TLR3 on the S100B/RAGE axis [55].
In toto, we have identified a mechanism that discriminates
between pathogen– and danger–induced immune responses via the
spatiotemporal integration of signals from different innate immune
biosensors. Conceptually, our study details an evolving braking
Figure 5. TLR3 and TLR9 inhibit s100b expression via TRIF/noncanonical NF–kB. (A) Levels of p38 phosphorylation on purified epithelial
cells from C57BL6 mice or TLR KO mice, unexposed (–) or exposed to Aspergillus resting (RC) or swollen (SC) conidia, 5 mg/ml MALP–2, 10 mg/ml
Poly(I:C) or 10 mg/ml ODN–CpG for 8 h. (B) Ifnb1 or Ifna1 gene expression by real time RT–PCR on epithelial cells from C57BL6 mice exposed to
Poly(I:C) in the presence of siS100B or 4 nM S100B. *P,0.05, siRNA –treated vs untreated cells. Representative of 2 experiments. (C) S100B co-
localization with fungal RNA in HEK293 cells pulsed with fungal RNA and stained with Syto17 red fluorescent nucleic acid stain and anti-S100B
antibody followed by FITC-conjugated goat anti–rabbit. Mock-pulsed (control) and pulsed cells were analyzed on confocal microscope. (D) Fungal
RNA stimulates epithelial cells via TLR3. Levels of IRF3 phosphorylation on lung epithelial cells exposed to Poly(I:C) or fungal RNA. Data are presented
as immunoblots of cell lysates and fold increases (pixel density) in the phosphorylated to total protein ratios. (E) Immunoblots and pixel density of
IKKb and IKKa phosphorylation in epithelial cells from C57BL6 mice exposed as in (A). (F) Results from an ELISA procedure to monitor activation of
p65, p52, and RelB in nuclear extract from epithelial cells exposed as in (A) for different lengths of time. Time 0 indicates untreated cells. Relative
activities (A450) are mean6SE of two experiments, each in triplicate. *P,0.05, treated vs untreated cells. (G) s100b gene expression by real time RT–
PCR upon canonical/noncanonical NF–kB inhibition by siRNA in epithelial cells exposed to MALP–2 or Poly(I:C), as above. SB202190 (5 mM) was used
as p38 inhibitor. *P,0.05, siRNA–treated or p38–inhibited cells vs MALP–2 or Poly(I:C)–exposed cells. Representative of 2 experiments.
doi:10.1371/journal.ppat.1001315.g005
Figure 6. S100B activity in vivo is contingent upon TLR signaling. Fungal growth (CFU6SE) (A) and (B) Mpo expression by real time RT–PCR in
the lung of TLR–deficient mice infected with Aspergillus conidia and treated with 50 ng/ml S100B as in legend to Fig. 3. Data were obtained at 3 days
postinfection. Representative of 4 experiments. P, treated vs untreated (None) mice.
doi:10.1371/journal.ppat.1001315.g006
TLR/RAGE Cross-Talk in Inflammation
PLoS Pathogens | www.plospathogens.org 10 March 2011 | Volume 7 | Issue 3 | e1001315circuit in infection whereby an endogenous danger protects the host
against pathogen–induced inflammation and a nucleic acid–sensing
mechanism terminates danger–induced inflammation. Thus, in
addition to the notion that danger signal may terminate overactive
immune responses [10], our study reveals that a pathogen–induced
signal may also terminate unnecessary danger–induced injury. This
raises the intriguing possibility that the host may have developed
mechanisms to ameliorate the response to DAMPs via PAMPs. The
scenario is dominated by the highly adaptive S100B/RAGE axis
that, in sensing danger, plays a critical and unanticipated role as a
fine modulator of inflammation via the promiscuous activity of
S100B at the extracellular and intracellular levels. On a
translational level, our findings suggest that a defective danger
sensing associated with the different isoforms of the RAGE receptor
may underlie individual differences in the clinical course of invasive
aspergillosis and the inherent patient’s susceptibility to infection.
Materials and Methods
Ethics statement
Experiments were performed according to the Italian Approved
Animal Welfare Assurance A–3143–01. Legislative decree 157/
2008-B regarding the animal licence obtained by the Italian
Ministry of Health lasting for three years (2008–2011). Infections
were performed under avertin anesthesia and all efforts were made
to minimize suffering.
Mice
Female C57BL6 mice, 8–10 wk old, mice were purchased from
Charles River (Calco, Italy). Homozygous Tlr2–/–, Tlr3–/–,
Tlr4–/–, Tlr9–/–, Myd88–/– and Trif–/– mice on a C57BL6
background were bred under specific pathogen–free conditions at
the Animal Facility of Perugia University, Perugia, Italy.
RAGE–/– mice were obtained from Dr. Angelika Bierhaus
(Heidelberg, Germany). s100b–EGFP+ transgenic mice [56] were
obtained from Dr. Catherine Legraverend (Montpellier, France).
Fungal strains, infections, and treatments
The strain of A. fumigatus was obtained as described [25]. Viable
resting, swollen Aspergillus conidia and hyphae were obtained as
described [30]. For infection, mice were anesthetized by
intraperitoneal (i.p.) injection of 2.5% avertin (Sigma Chemical
Co, St. Louis, MO) before instillation of a suspension of 2610
7
conidia/20 ml saline intranasally (i.n.). Fungi were suspended in
endotoxin–free (Detoxi–gel; Pierce, Rockford, IL) solutions
(,1.0 EU/mL, as determined by the LAL method). Mice were
Figure 7. Spatiotemporal integration of signals from TLRs and RAGE by S100B limits pathogen– and danger–induced inflammation.
The figure shows that TLR2 activation on epithelial cells by the fungus resulted in the release of the Ca
2+–binding protein, S100B, that paracrinally
binds to RAGE, on polymorphonuclear neutrophils, and mediates its association with TLR2 with subsequent inhibition. However, S100B, upon
binding to nucleic acids, also activates an intracellular TLR3/TLR9/TRIF–dependent pathway culminating in the transcriptional down-regulation of
S100B. The transcriptional regulation of S100B by the sequential action of downstream MyD88– and TRIF–dependent NF–kB signalling pathways
provides the molecular basis for an evolving braking circuit in infection whereby the endogenous danger protects the host against pathogen–
induced inflammation and a nucleic acid–sensing mechanism resolves danger–induced chronic inflammation.
doi:10.1371/journal.ppat.1001315.g007
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organ, mean 6 SE]. BAL was performed by cannulating the
trachea and washing the airways with 3 ml of PBS to collect the
BAL fluid. Total and differential cell counts were done by staining
BAL smears with May–Gru ¨nwald Giemsa reagents (Sigma) before
analysis. At least 200 cells per cytospin preparation were counted
and the absolute number of each cell type was calculated.
Photographs were taken using a high–resolution Microscopy
Olympus DP71 (Olympus, Milan, Italy). Mice were treated daily
i.p. for 3 consecutive days starting the day of the infection with
different doses of purified S100B (see below), 1 mg/kg polyclonal
rabbit anti–S100B antibodies (Swant, CH–6501 Bellinzona,
Switzerland) or 0.5 mg/kg anti–RAGE goat polyclonal IgG
(Santa Cruz Biotechnology, inc. DBA, Milan, Italy). Control
received PBS or isotype controls (Sigma–Aldrich).
In vivo treatments with TLR agonists
MALP–2 (2.5 mg), Poly(I:C) (50 mg), ultrapure LPS from
Salmonella minnesota Re 595 (10 mg) (all from Sigma Chemical Co)
and Class B ODN–CpG (50 mg) [24] were given once intranasally
to mice infected as above. Control received PBS or isotype
controls (Sigma–Aldrich). Mice were sacrificed three days after
treatment for histology (H&E staining) and s100b expression by
real–time RT–PCR. Control received PBS.
Histology, fluorescence and immunohistochemistry
For histology, sections of paraffin–embedded tissues were
stained with the periodic acid–Schiff (PAS), hematoxylin and
eosin (H&E) or Gomori’s methenamine Silver procedures [25].
For detecting S100B–expressing cells, lungs in OCT or purified
cells from s100b–EGFP mice were analyzed. For immunohisto-
chemistry, lung sections were incubated overnight with polyclonal
anti–S100B antibody (1:100) or polyclonal anti–RAGE antibody
(1:20) followed by the secondary antibodies, i.e., tetramethyl
rhodamine isocyanate–conjugated goat anti–rabbit IgG (Sigma–
Aldrich) for S100B, and AlexaFluor 594 donkey anti–goat IgG
(Invitrogen), for RAGE. Nuclei were counter–stained with 49,6-
diamidino-2-phenylindole (DAPI). Endogenous peroxidase activity
was quenched using 3% H2O2 in PBS. Immunostaining of lungs
from RAGE KO mice was used as negative controls. Fluorescence
and immunofluorescence microscopy was performed on a DM Rb
epifluorescence microscope equipped with a digital camera (Leica,
Wetzlar, Germany).
Cell preparation, cultures and treatments
Purified lung CD11b
+Gr–1
+ PMNs (.98% pure on FACS
analysis) were obtained as described [34]. Lung epithelial cells, at
,99% expressing cytokeratin, on pan–cytokeratin antibody
staining of cytocentrifuge preparations, and .90% viable on
trypan blue exclusion assay, were isolated as described [57].The
average yield of tracheal cells was 1.7610
5 cells/trachea
[60.58610
5 (SD)]. Alveolar macrophages were purified by plastic
adherence. Total lung cells, purified alveolar macrophages and
PMNs were incubated with unopsonized resting conidia at 1:1
ratio at 37uC for conidiocidal activity [percentage of colony
forming units inhibition (mean 6 SE) at 60 min] or oxidant
production [oxidation of dihydrorhodamine 123 (DHR), Molec-
ular Probes (Invitrogen S.R.L. San Giuliano Milanese, Milan,
Italy, measured by fluorimetry with the multifunctional microplate
reader Tecan Infinite 200, Tecan Austria GmbH, Salzurg,
Austria) at different time points. PMNs or epithelial cells were
exposed to nanomolar or micromolar S100B as described [58],
20 mg/ml anti–S100B antibody (SWant), 300 nM HMGB1, 5 mg/
ml MALP–2, 10 mg/ml Poly(I:C), 10 mg/ml ultrapure LPS from
Salmonella minnesota Re 595 and 10 mg/ml ODN–CpG. In vitro
experiments were done in the presence of 2% FBS. Control cells
were treated with PBS, DMSO or control antibody.
S100B binding assays
S100B binding to TLR ligands was assessed in solid phase by
ELISA. Briefly, plates were coated overnight at 4uC with 10 mg/
ml (based on preliminary experiments) of MALP–2, Zymosan
(Sigma Aldrich), HSP70 (StressMarq Biosciences Inc, Victoria
Canada), Poly(I:C) or LPS in carbonate buffer (pH 9.55) or total
fungal DNA or RNA, human DNA, Class B ODN–CpG (2006),
non-CpG ODN (ODN 1982) [24], resiquimod (R–848, Invivogen,
Labogen S.r.l. Rho, Italy) in Reacti–Bind
TM DNA Coating
Solution (Pierce). Fungal DNA and RNA were obtained as
described [50]. Total fungal RNA was routinely pretreated with
RNase–free DNase I (50 units of DNase I/100 mg RNA) (Sigma
Aldrich) at 25uC for 2 h. Nanomolar or micromolar S100B was
added in blocking buffer (TBS 1%BSA) for 2 h at room
temperature followed by the addition of rabbit anti–S100B
antibodies (1:1000) and HRP–conjugated rabbit secondary
antibody (R&D Systems, Space Import–Export srl Milano, Italy).
EGTA was used at 1 mM. The plates were developed using TMB
Microwell Peroxidase Substrate system (BioFX Laboratories, Inc
MD, U/SA). ODs were read at 450 nm. Data indicate the mean
6SE of triplicates from three independent experiments.
Syto17 red fluorescent nucleic acid stain
To detect S100B co-localization with fungal RNA, TLR2–
transfected HEK293 cells were pulsed with fungal RNA by
means of N-[1-(2,3-dioleoyloxypropyl]-N,N,N,-trimethylammo-
nium methylsulfate (DOTAP; Roche), as described [50]. After
pulsing cells were fixed in 3.7% formaldehyde, Triton–X100
permeabilized and incubated with Syto17 red fluorescent universal
nucleic acid stain (Molecular Probe; 2.5 mM, 5 min) and anti-
S100B antibody (1:20 dilution) followed by FITC-conjugated goat
anti–rabbit IgG (Vector Laboratories). Mock-pulsed (control) and
pulsed cells were analyzed on confocal microscope Nikon Eclipse
TE-2000U (Tokyo, Japan).
Western blotting
Blots of cells lysates were incubated with monoclonal rabbit
monoclonal anti–S100B IgG (clone EP1576Y, Epitomics, CA),
goat polyclonal anti–RAGE IgG (Santa Cruz Biotechnology, Inc.),
rabbit anti–HMGB1 IgG2a (Calbiochem, Milan, Italy), mouse
monoclonal anti–TLR2 IgG2a, Santa Cruz Biotechnology, Inc.),
rabbit polyclonal Abs recognizing the unphosphorylated form of
ERK and p38 followed by horseradish peroxidase–conjugated
anti–goat, mouse or rabbit IgG (Cell Signaling Technology) or
biotin–conjugated (Vectastain Elite ABC system; Vector Labora-
tories, Burlingame, CA, USA) secondary antibodies. Blots were
developed with the Enhanced Chemiluminescence detection kit
(Amersham Pharmacia Biotech, Milan, Italy) and SuperSignal
West Pico (Pierce). Scanning densitometry was done on a Scion
Image apparatus. The pixel density of bands was normalized
against total proteins or tubulin. The inhibitor p38 (5 mM,
SB202190) was purchased from Calbiochem (San Diego, CA)
and dissolved at 10006the final concentration in DMSO (Sigma).
Control experiments included staining without the primary
antibody.
Co–immunoprecipitation
The human HEK293 embryonic kidney cell lines stably
transfected with human TLR2 were maintained as described
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without 4 nM or mM S100B or 20 mg/ml anti–S100B antibodies
(SWant). Cell lysates were subjected to immunoprecipitation after
overnight incubation with 2 mg/ml polyclonal anti–S100B
(SWant) or anti–RAGE (Santa Cruz Biotechnology, Inc) antibody.
Immunoprecipitates were probed with antibodies to the corre-
sponding antigens. Control experiments included western blottings
on immunoprecipated with an irrelevant antibody.
In situ proximity ligation assay (PLA)
We resorted to PLA [59] to directly visualize the RAGE
interaction with TLR2 in an S100B–dependent manner. TLR2–
transfected HEK293 cells were transiently transfected with a
RAGE expression vector (pcDNA3/RAGE) or empty vector
(pcDNA3) and stimulated with MALP–2 for 30 min with or
without 4 nM or mM S100B or 20 mg/ml anti–S100B antibody
(SWant). Cells were then fixed in cold methanol and treated with a
rabbit anti–RAGE (H300, Santa Cruz Biotechnology, Inc) and a
goat anti–TLR2 antibody, and subjected to PLA (OLINK
Bioscience, Uppsala) according to the manufacturer’s instructions.
Cells were visualized on the DM Rb epifluorescence microscope.
Canonical and noncanonical NF–kB
To detect NF–kB (p65) nuclear translocation, purified PMNs
were fixed in cold methanol, permeabilized with Triton-X100
0.1% in PBS, incubated with blocking solution (PBS containing
3% BSA and 1% glycine), and incubated overnight at 4uC with
rabbit anti-p65 (C-20) antibody (sc-372, Santa Cruz Biotechnol-
ogy; 1:50 dilution) followed by tetramethyl rhodamine isocyanate-
conjugated goat anti-rabbit IgG (Sigma-Aldrich; 1:50 dilution) as
secondary antibody. Nuclei were counter-stained with DAPI. Cells
were visualized on the epifluorescence microscope. We used an
ELISAbased TransAM Flexi NFkB Family Kit (Active Motif) to
monitor activity of NF–kB family members. Anti–phospho–IKKa
(Ser180)/IKKb (Ser181) rabbit Abs (Cell Signaling Technology)
were used for western blotting of phospho IKKa and IKKb.
Western blotting with specific polyclonal antibodies (Santa Cruz
Biotechnology) was done to assess level of p65.
Exposure of epithelial cells to fungal RNA
Epithelial cells were exposed to fungal RNA (25 mg/ml) [50] for
8 h before determination of levels of IRF3 phosphorylation by
immunoblotting with rabbit polyclonal anti–IRF3 antibodies and
anti–rabbit–horseradish peroxidase (Santa Cruz Biotechnology
Inc.). Data are presented as immunoblots of cell lysates and fold
increases (pixel density) in the phosphorylated to total protein
ratios.
Expression and purification of S100B
Recombinant bovine S100B, 97% identical to mouse S100B,
was expressed and purified as reported [31,32]. Purified S100B
was passed through END–X B15 Endotoxin Affinity Resin
column to remove contaminating bacterial endotoxin. The
S100B concentration was calculated using the Mr of the S100B
dimer (21 kDa).
SiRNA synthesis and transfection
SiRNA to target IKKa, IKKb and S100B were done as
described [30]. The siRNA specific sequences were selected,
synthesized and annealed by the manufacturer, and were used in
combination with nontargeted control siRNA (Ambion, Applied
Biosystem International, Monza Italy). Transfections of siRNA (at
1 nM/well) were performed by using the INTERFERin
TMTrans-
fection reagent, as per manufacturer’s instructions (PEQLAB
Biotechnologie GmbH, Erlangen, Germany). Cells were stimulat-
ed 48 h after transfection at 37uC. Expression of IKKa, IKKb and
S100B transcripts in transfected cells was evaluated by RT–PCR
or western blotting.
Reverse transcriptase–PCR and real–time PCR
Real–time RT–PCR was performed using the iCycler iQ
detection system (Bio–Rad) and SYBR Green chemistry (Finn-
zymes Oy, Espoo, Finland). Cells were lysed and total RNA was
extracted using RNeasy Mini Kit (QIAGEN, Milan, Italy) and was
reverse transcribed with Sensiscript Reverse Transcriptase (QIA-
GEN) according to the manufacturer’s directions. The sense/
antisense primers were as follows: Ager sense 59–GCCCTCATT-
GATGTCTTCCACC–39; antisense (59–GAACTCATGGCAG-
GCCGTGGTC–39); s100b sense 59–GCCCTCATTGATG-
TCTTCCACC–39; antisense 59–GAACTCATGGCAGGCCG-
TGGTC–39; s100a8 sense 59–TCGTGACAATGCCGTCT-
GAACTG–39; antisense 59–TGCTACTCCTTGTGGCTGT-
CTTTG–39; s100a9, sense 59– CGCAGCATAACCACCAT-
CATC–39; antisense 59–GCCATCAGCATCATACACTCC–39;
Hmgb1 sense, 59–GGCTGACAAGGCTCGTTATG–39; anti-
sense 59–GCAACATCACCAATGGATAAGC–39;Fas sense 59–
CTACTGCGATTCTCCTGGCTGTG–39; antisense 59–AGT-
TTGTATTGCTGGTTGCCTGTGC–39; Bcl2 sense 59–AC-
GAGTGGGATGCTGGAGATG–39; antisense 59–TCAGGCT-
GGAAGGAGAGATGC–39. Other primers were as described
[30] Amplification efficiencies were validated and normalized
against Gapdh. The thermal profile for SYBR Green real time PCR
was at 95uC for 3 min, followed by 40 cycles of denaturation for
30 s at 95uC and an annealing/extension step of 30 sec at 60uC.
Each data point was examined for integrity by analysis of the
amplification plot. The mRNA–normalized data were expressed
as relative cytokine mRNA in stimulated cells compared to that of
mock–infected cells.
Statistical analysis
Data were analyzed by GraphPad Prism 4.03 program
(GraphPad Software, San Diego, CA). Student’s t test or analysis
of variance (ANOVA) and Bonferroni’s test were used to determine
the statistical significance(P) of differences inorgan clearance and in
vitro assays. The data reported are either from one representative
experiment out of three to five independent experiments (western
blotting and RT–PCR) or pooled from three to five experiments,
otherwise. The in vivo groups consisted of 6–8 mice/group.
Supporting Information
Figure S1 RAGE and DAMPs expression in pulmonary
aspergillosis. (A) Expression of Ager, hmgb1, s100b, s100a8 and
s100a9 by real time RT-PCR on lung of C57BL6 mice at different
days postinfection (dpi) with Aspergillus conidia intranasally.
Representative of 2 experiments. (B) S100B-expression on purified
cells from transgenic mice expressing s100b-EGFP+ infected with
Aspergillus conidia 3 days before. MØ alveolar macrophages, DC,
dendritic cells, PMN, polymorphonuclear neutrophils. (C) Expres-
sion of Ager by RT-PCR on purified lung cells from uninfected
C57BL6 mice. Microscopy was performed on a DM Rb
epifluorescence microscope equipped with a digital camera.
Representative of 2 experiments.
Found at: doi:10.1371/journal.ppat.1001315.s001 (0.41 MB TIF)
Figure S2 RAGE-deficient mice develop pathogen-induced Th
inflammation. (A) Purified DCs from uninfected mice were
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before real time RT-PCR. (B) Cytokine gene-expression by real-
time RT-PCR in DCs from RAGE KO or WT uninfected mice
exposed to MALP-2, LPS or ODN-CpG for 18 h. (C) Freshly
isolated CD4+T cells from TLN were assessed for transcription
factor expression by RT-PCR. P, KO vs WT mice. P, KO vs WT
mice. Data are pooled from 4 experiments or representative of 2
experiments (for histology). Representative of 2 experiments. P,
KO vs WT DCs. N.D., not determined.
Found at: doi:10.1371/journal.ppat.1001315.s002 (0.57 MB TIF)
Figure S3 Effects of HMGB1 administration in mice with
aspergillosis. Fungal growth (CFU6SE) (A) and lung histology
(PAS staining) (B) in C57BL6 or RAGE KO mice infected with
Aspergillus live conidia intranasally and treated intraperitoneally
for 3 consecutive days with 50 mg/kg HMGB1. P, treated vs
untreated (-) mice. Representative of 3 experiments. *P,0.05,
treated vs untreated (-) cells.
Found at: doi:10.1371/journal.ppat.1001315.s003 (0.65 MB TIF)
Figure S4 Effect of S100B on A. fumigatus morphology and
germination. Germination refers to the percentages (mean 6 SE)
of germinating cells over a total of 400 cells counted. Magnifica-
tion x 40. Shown are the pooled results from 2 experiments.
Photographs were taken using a high Resolution Microscopy
Color Camera AxioCam, using the AxioVision Software Rel. 3.1
(Carl Zeiss S.p.A., Milano, Italy).
Found at: doi:10.1371/journal.ppat.1001315.s004 (1.25 MB TIF)
Text S1 Supplemental methods referred to Supplemental
Figures S1, S3, S4.
Found at: doi:10.1371/journal.ppat.1001315.s005 (0.04 MB
DOC)
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